Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: NMR Biomed. 2015 Oct 9;28(12):1645–1654. doi: 10.1002/nbm.3412

Table 2.

Pretreatment and midtreatment IVIM parameters

Midtreatment assessment ADC (mm2/s, ×10−3) D* (mm2/s, ×10−2) D (mm2/s, ×10−3) f (mm2/s)

Pre-Tx Mid-Tx Pre-Tx Mid-Tx Pre-Tx Mid-Tx Pre-Tx Mid-Tx

CR (n = 19) 0.83 ± 0.17 1.7 ± 0.33 3.0 ± 1.2 3.4 ± 0.12 0.69 ± 0.13 1.5 ± 0.27 0.14 ± 0.05 0.25 ± 0.10

Non-CR (n = 40) 0.94 ± 0.19 1.3 ± 0.30 3.0 ± 1.4 3.5 ± 0.13 0.82 ± 0.15 1.2 ± 0.29 0.13 ± 0.06 0.16 ± 0.08

Total (n = 59) 0.9 ± 0.19 1.4 ± 0.35 3.0 ± 1.3 3.5 ± 1.2 0.78 ± 0.16 1.3 ± 0.31 0.13 ± 0.05 0.19 ± 0.1

Note.—Tx = treatment, CR = complete response. The data are means with standard deviations.

Significant P = .003 for pre-Tx ADC and D values in the CR group vs. the non-CR.

Significant P < .0001 for mid-Tx ADC, D, and f parameters increase vs. the pre-Tx values.